Cardlytics Inc (CDLX) Shares Bought by Prescott Group Capital Management L.L.C.

Prescott Group Capital Management L.L.C. lifted its position in Cardlytics Inc (NASDAQ:CDLX) by 16.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 35,000 shares of the company’s stock after purchasing an additional 5,000 shares during the quarter. Prescott Group Capital Management L.L.C.’s holdings in Cardlytics were worth $876,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. California State Teachers Retirement System acquired a new stake in Cardlytics during the first quarter worth about $122,000. Wells Fargo & Company MN grew its holdings in Cardlytics by 72.4% during the third quarter. Wells Fargo & Company MN now owns 8,004 shares of the company’s stock worth $201,000 after acquiring an additional 3,361 shares during the period. Schwab Charles Investment Management Inc. acquired a new stake in Cardlytics during the second quarter worth about $214,000. Rockefeller Capital Management L.P. acquired a new stake in Cardlytics during the third quarter worth about $231,000. Finally, Bank of New York Mellon Corp grew its holdings in Cardlytics by 32.9% during the second quarter. Bank of New York Mellon Corp now owns 15,553 shares of the company’s stock worth $338,000 after acquiring an additional 3,846 shares during the period. Hedge funds and other institutional investors own 60.76% of the company’s stock.

CDLX has been the topic of several research analyst reports. Zacks Investment Research raised Cardlytics from a “hold” rating to a “buy” rating and set a $16.00 price objective on the stock in a report on Monday, November 19th. Raymond James dropped their price objective on Cardlytics from $23.00 to $20.00 and set an “outperform” rating on the stock in a report on Wednesday, November 14th. JPMorgan Chase & Co. dropped their price objective on Cardlytics from $31.00 to $25.00 and set an “overweight” rating on the stock in a report on Wednesday, November 14th. Morgan Stanley dropped their price objective on Cardlytics from $28.00 to $26.00 and set an “overweight” rating on the stock in a report on Wednesday, November 14th. Finally, SunTrust Banks reissued a “buy” rating and issued a $27.00 price objective on shares of Cardlytics in a report on Tuesday, September 11th. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $23.25.

In other Cardlytics news, Director Polaris Venture Management Co. sold 150,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 13th. The stock was sold at an average price of $25.04, for a total value of $3,756,000.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Shares of CDLX opened at $14.79 on Friday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 3.04 and a current ratio of 3.04. Cardlytics Inc has a 12 month low of $11.10 and a 12 month high of $28.29.

Cardlytics (NASDAQ:CDLX) last issued its quarterly earnings data on Tuesday, November 13th. The company reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.63) by $0.48. The business had revenue of $34.58 million during the quarter, compared to analyst estimates of $37.62 million. Cardlytics’s quarterly revenue was up 10.1% compared to the same quarter last year. Analysts anticipate that Cardlytics Inc will post -2.08 earnings per share for the current fiscal year.

WARNING: “Cardlytics Inc (CDLX) Shares Bought by Prescott Group Capital Management L.L.C.” was originally posted by WKRB News and is owned by of WKRB News. If you are viewing this article on another domain, it was illegally stolen and republished in violation of international copyright & trademark legislation. The original version of this article can be accessed at https://www.wkrb13.com/2018/11/24/cardlytics-inc-cdlx-shares-bought-by-prescott-group-capital-management-l-l-c.html.

About Cardlytics

Cardlytics, Inc operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels.

Featured Story: Balanced Fund

Want to see what other hedge funds are holding CDLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardlytics Inc (NASDAQ:CDLX).

Institutional Ownership by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply